Sudarshan Velpari

NPI: 1235450263
Total Payments
$20,778
2024 Payments
$3,081
Companies
55
Transactions
1,505
Medicare Patients
3,516
Medicare Billing
$670,928

Payment Breakdown by Category

Food & Beverage$20,753 (99.9%)
Education$24.99 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $20,753 1,502 99.9%
Education $24.99 3 0.1%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $3,052 183 $0 (2024)
Novo Nordisk Inc $2,133 183 $0 (2024)
ABBVIE INC. $1,324 119 $0 (2024)
Merck Sharp & Dohme LLC $1,147 72 $0 (2023)
SANOFI-AVENTIS U.S. LLC $1,077 71 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,050 99 $0 (2024)
Janssen Pharmaceuticals, Inc $952.58 72 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $935.80 68 $0 (2024)
GlaxoSmithKline, LLC. $910.80 65 $0 (2024)
Allergan, Inc. $856.00 64 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,081 192 AstraZeneca Pharmaceuticals LP ($693.04)
2023 $2,765 206 AbbVie Inc. ($386.33)
2022 $2,733 211 AstraZeneca Pharmaceuticals LP ($323.74)
2021 $2,484 191 Novo Nordisk Inc ($371.82)
2020 $2,232 169 Novo Nordisk Inc ($341.05)
2019 $3,121 229 AstraZeneca Pharmaceuticals LP ($454.36)
2018 $2,421 195 Novo Nordisk Inc ($355.56)
2017 $1,940 112 Merck Sharp & Dohme Corporation ($287.02)

All Payment Transactions

1,505 individual payment records from CMS Open Payments — Page 1 of 61

Date Company Product Nature Form Amount Type
12/23/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $11.63 General
Category: Diabetes
12/18/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.45 General
Category: Cardiovascular and Metabolism
12/12/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.58 General
Category: PSYCHIATRY
12/10/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.34 General
Category: Inflammation
12/05/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $113.60 General
Category: Respiratory
12/05/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $16.51 General
Category: Diabetes
12/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.91 General
Category: NEUROSCIENCE
12/05/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $1.70 General
Category: Diabetes
12/04/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $31.57 General
Category: Oncology
11/27/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.61 General
Category: Cardiovascular and Metabolism
11/26/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $18.60 General
Category: Anticholinergics, Inhaled
11/25/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $14.22 General
Category: ANTIBIOTIC
11/21/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.17 General
Category: Respiratory
11/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.56 General
Category: NEUROSCIENCE
11/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.81 General
Category: DIABETES
11/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.00 General
Category: NEUROSCIENCE
11/19/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $15.62 General
Category: DIABETES
11/12/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $17.50 General
Category: PAIN
11/07/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $12.64 General
Category: Diabetes
11/06/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.95 General
Category: Respiratory
11/04/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $24.43 General
Category: Oncology
10/31/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $16.84 General
Category: Analgesic
10/31/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $5.00 General
Category: NEUROSCIENCE
10/29/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $17.04 General
Category: Cardio-renal
10/24/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.50 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 922 1,959 $566,450 $182,757
2022 19 914 2,188 $568,721 $176,377
2021 22 960 1,981 $526,774 $172,140
2020 21 720 1,739 $456,660 $139,654
Total Patients
3,516
Total Services
7,867
Medicare Billing
$670,928
Procedure Codes
79

All Medicare Procedures & Services

79 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 47 589 $151,223 $50,854 33.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 245 515 $170,173 $46,133 27.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 50 181 $52,610 $18,065 34.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 76 100 $46,872 $15,595 33.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 58 58 $18,573 $8,235 44.3%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 41 41 $19,352 $7,422 38.4%
99497 Advance care planning, first 30 minutes Office 2023 83 83 $18,727 $7,104 37.9%
99310 Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 25 47 $17,674 $5,906 33.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 37 53 $15,885 $5,124 32.3%
90662 Influenza vaccine split virus, preservative free Office 2023 49 49 $7,173 $3,525 49.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 26 34 $12,862 $3,511 27.3%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 19 19 $9,015 $2,827 31.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 18 35 $6,926 $2,341 33.8%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 13 13 $6,140 $2,310 37.6%
G0008 Administration of influenza virus vaccine Office 2023 53 53 $2,650 $1,800 67.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $6,923 $1,220 17.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 70 77 $3,673 $784.46 21.4%
99309 Follow-up nursing facility visit per day, typically 25 minutes Facility 2022 65 774 $192,726 $57,535 29.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 249 537 $159,840 $48,749 30.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 62 203 $57,246 $17,839 31.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 53 60 $24,150 $9,079 37.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 40 40 $12,680 $5,814 45.8%
99306 Initial nursing facility visit per day, typically 45 minutes Facility 2022 37 42 $19,278 $5,672 29.4%
99310 Follow-up nursing facility visit per day, typically 35 minutes Facility 2022 23 47 $17,390 $5,300 30.5%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 44 55 $16,115 $5,019 31.1%

About Sudarshan Velpari

Sudarshan Velpari is a Internal Medicine healthcare provider based in Jersey City, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1235450263.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sudarshan Velpari has received a total of $20,778 in payments from pharmaceutical and medical device companies, with $3,081 received in 2024. These payments were reported across 1,505 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($20,753).

As a Medicare-enrolled provider, Velpari has provided services to 3,516 Medicare beneficiaries, totaling 7,867 services with total Medicare billing of $670,928. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Jersey City, NJ
  • Active Since 06/14/2010
  • Last Updated 02/20/2017
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1235450263

Products in Payments

  • FARXIGA (Drug) $1,524
  • Ozempic (Drug) $983.16
  • VRAYLAR (Drug) $975.38
  • XIFAXAN (Drug) $834.87
  • JARDIANCE (Drug) $804.50
  • XARELTO (Drug) $747.71
  • Kerendia (Drug) $670.44
  • Vascepa (Drug) $666.80
  • AFREZZA (Drug) $664.02
  • AIRSUPRA (Drug) $559.71
  • BELSOMRA (Drug) $486.68
  • SOLIQUA 100/33 (Biological) $472.17
  • NUZYRA (Drug) $451.73
  • UBRELVY (Drug) $412.10
  • JANUVIA (Drug) $400.39
  • BREZTRI (Drug) $372.96
  • TRELEGY ELLIPTA (Drug) $360.13
  • ANORO (Drug) $300.46
  • BYSTOLIC (Drug) $294.85
  • Otezla (Drug) $293.43

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Jersey City